| Type | Investment In | Percentage of NAV | No. of shares | Value(Rs in cr) |
| Domestic Equities | Sun Pharmaceutical Industries Ltd. | 11.2179 | 52436 | 9.4820 |
| Domestic Equities | Apollo Hospitals Enterprise Ltd. | 6.5203 | 7217 | 5.5113 |
| Domestic Equities | Torrent Pharmaceuticals Ltd. | 6.5010 | 13130 | 5.4950 |
| Domestic Equities | Aurobindo Pharma Ltd. | 5.1456 | 31301 | 4.3493 |
| Domestic Equities | Divi's Laboratories Ltd. | 4.7373 | 6158 | 4.0042 |
| Domestic Equities | Fortis Healthcare Ltd. | 4.6987 | 43032 | 3.9716 |
| Domestic Equities | Neuland Laboratories Ltd. | 4.5883 | 2585 | 3.8783 |
| Domestic Equities | Onesource Specialty Pharma Ltd. | 4.5566 | 22159 | 3.8515 |
| Domestic Equities | Piramal Pharma Ltd. | 4.3297 | 226088 | 3.6597 |
| Domestic Equities | Glenmark Pharmaceuticals Ltd. | 3.4145 | 11994 | 2.8861 |
| Domestic Equities | Navin Fluorine International Ltd. | 3.3215 | 4116 | 2.8075 |
| Domestic Equities | Alkem Laboratories Ltd. | 3.1994 | 5008 | 2.7043 |
| Domestic Equities | Cipla Ltd. | 3.0316 | 19567 | 2.5625 |
| Domestic Equities | IPCA Laboratories Ltd. | 3.0073 | 16604 | 2.5419 |
| Domestic Equities | Abbott India Ltd. | 2.9129 | 968 | 2.4621 |
| Domestic Equities | Gland Pharma Ltd. | 2.9087 | 14043 | 2.4586 |
| Domestic Equities | Concord Biotech Ltd. | 2.7738 | 20531 | 2.3446 |
| Domestic Equities | Artemis Medicare Services Ltd. | 2.7013 | 93529 | 2.2833 |
| Domestic Equities | Metropolis Healthcare Ltd. | 2.6667 | 47304 | 2.2540 |
| Domestic Equities | Mankind Pharma Ltd. | 2.2798 | 8577 | 1.9270 |
| Domestic Equities | Anthem Biosciences Ltd. | 2.2781 | 25333 | 1.9256 |
| Domestic Equities | Dr Agarwal's Health Care Ltd. | 2.0840 | 39576 | 1.7615 |
| Domestic Equities | Global Health Ltd. | 1.9763 | 14952 | 1.6705 |
| Domestic Equities | Max Healthcare Institute Ltd. | 1.9708 | 16775 | 1.6658 |
| Domestic Equities | Acutaas Chemicals Ltd. | 1.9322 | 6296 | 1.6332 |
| Domestic Equities | Vinati Organics Ltd. | 1.3674 | 8741 | 1.1558 |
| Total | | 96.1216 | | 81.2472 |
| Cash & Cash Equivalents and Net Assets | Treps | 4.1675 | | 3.5226 |
| Cash & Cash Equivalents and Net Assets | Net Receivables / (Payables) | -0.2891 | | -0.2444 |
| Total | | 3.8784 | | 3.2782 |